BridgeMD
New treatment option for Bleeding
Official title How Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study
ClinicalTrials.gov ID: NCT06938789
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate whether early detection of bleeding and prompt blood transfusions can help prevent delirium in patients aged 75 and older who are admitted to the hospital with hip fractures. The main question the trial aims to answer is: Do patients aged 75 and older with hip fractures benefit from earlier treatment of anemia (low blood count) to reduce the risk of delirium?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 and older
You may be able to join if
- Hip fracture
You likely can't join if
- Pathological hip fracture
- Periprosthtic fracture
- Unable to speak or understand Danish
- Does not wish to recieve blood transfusion
- If the investigator finds the patient unable to cooperate to the study (e.g. in case of severe dementia and externalizing behaviour)
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus, Central Jutland, Denmark
- Herning, Central Jutland, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus, Central Jutland, Denmark; Herning, Central Jutland, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.